You have read all your free articles, to continue reading subscribe to read the rest of this content.
Tomas Lundqvist has a long and prosperous career within structural biology and drug discovery and is from January 1st 2014 Life Science Director at MAX IV Laboratory. ”I am very happy and extremely proud for being given this chance to be part of the great team at MAX IV Laboratory,”…
The Board of Directors has appointed Professor Börje Haraldsson as CEO of the company. “I and the Board as a whole are delighted that Börje Haraldsson is expanding his involvement in Oncorena and takes on the role as CEO of the company. Oncorena is now entering a dynamic clinical phase…
BioInvent International has announced the appointment of Marie Moores as Chief Operating Officer. Marie Moores joined the company on February 1, 2022, and she will be involved in all operational aspects including quality assurance as well as commercial strategy planning such as further developingAlready a subscriber Login You have read…
The two companies announce that the European Commission has granted a marketing authorization for Ximluci (ranibizumab), a biosimilar candidate referencing Lucentis. This follows the positive opinion issued by the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Already a subscriber Login You have read all your free articles,…
